Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Hepatitis B virus surface antigen (HBsAg)
- Target
- HBsAg
- Molecular classification
- Glycoprotein, Integral membrane protein
01
Overview
Hepatitis B virus surface antigen is a critical structural glycoprotein essential for viral infectivity, pathogenesis, diagnosis, and prevention through vaccination. Its detection remains central to clinical management of hepatitis B infections worldwide.
- Other names
- Australia antigen
02
Mechanism of action
Neutralization of infectious virus particles by anti-HBs antibodies
03
Biological functions
Viral entry receptor bindingImmune evasion
04
Disease associations
InfectionLiver inflammationCirrhosisHepatocellular carcinoma
05
Biomarkers
HBsAg serum levels (diagnosis, monitoring)
Beyond the preview
Go deeper on Hepatitis B virus surface antigen (HBsAg).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Hepatitis B virus surface antigen (HBsAg).